Home / News / India News / Article /
Bharat Biotech launches oral vaccine against cholera, targets 200 million dose production
Updated On: 27 August, 2024 08:04 PM IST | Hyderabad | mid-day online correspondent
Although cholera is both preventable and treatable, the number of cases and deaths worldwide has been steadily increasing since 2021. From early 2023 to March this year, 824,479 cases and 5,900 deaths were reported across 31 countries, according to Bharat Biotech’s statement
Representational pic
Bharat Biotech International has introduced a new single-strain Oral Cholera Vaccine (OCV) called HILLCHOL®.
According to a statement from the company, HILLCHOL® was developed under licence from Hilleman Laboratories, which is funded by Merck (US) and Wellcome Trust (UK), to tackle cholera.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT